ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Cofetuzumab Biosimilar - Anti-CCK4 Antibody (PE) (A334173)

Recombinant humanized monoclonal antibody to CCK4 (PE) for Flow Cytometry.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Cofetuzumab Biosimilar - Anti-CCK4 Antibody (PE)
Description
Recombinant humanized monoclonal antibody to CCK4 (PE).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Conjugate

PE

Excitation: 565nm, Emission: 578nm

Purification
Affinity chromatography.
Concentration
Lot Specific
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.05% Proclin 300 and 1% BSA.
Storage
Store at 4°C. Do not freeze!
Synonyms
CCK-4, Colon carcinoma kinase 4, Inactive tyrosine-protein kinase 7, Protein-tyrosine kinase 7, Pseudo tyrosine kinase receptor 7, PTK7, Tyrosine-protein kinase-like 7
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Cofetuzumab Biosimilar - Anti-CCK4 Antibody (PE) (A334173)? Please let us know so that we can list the citation on this page.

Proteins predicted to interact with CCK4

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
98.3% Relevancy Score
95.2% Relevancy Score
93.7% Relevancy Score
92.3% Relevancy Score
89.1% Relevancy Score
88.2% Relevancy Score
87.9% Relevancy Score
86.9% Relevancy Score
82.4% Relevancy Score